Vyleesi
Active substance: bremelanotide
INJECTION · BREMELANOTIDE ACETATE 1.75 mg/.3mL
United StatesActive
Marketing holder: Cosette Pharmaceuticals, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- BREMELANOTIDE ACETATE · 1.75 mg/.3mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a12095-3e87-7a56-84d2-01f49ea41fbf;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0713-0897
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- SUBCUTANEOUS
Sources
- product · openFDA NDC · 0713-0897 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0713-0897 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0713-0897 · Verified 2026-10-09 · open in source